Results for 'Immunotherapy'
Monty Pal
Rewriting the Rules of Cellular Therapy
City of Hope, Monty Pal, Stephen Forman, hematologic malignancy, cellular immunotherapy, bone marrow, CAR-T cell therapy
Dr. Stephen Forman shares the past, present, and future of cellular therapy and how City of Hope is building care systems to reach more patients.
Jul 21st • 47 mins listen
Monty Pal
Expanding the Reach of TIL Therapy: What Will it Take?
City of Hope, Monty Pal, Kelly Mahuron, TIL, tumor-infiltrating lymphocyte, melanoma, oncolytic virus, pancreatic cancer, colorectal tumor, immunotherapyn
Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.
Aug 4th • 38 mins listen
Rebecca Previs
ctDNA Breakthroughs in Mesothelioma Care
Labcorp, Rebecca Previs, Mark Sausen, immunotherapy, mesothelioma, checkpoint blockade, ctDNA, imaging
Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.
Nov 3rd • 15 mins listen
Monty Pal
Translating Discovery: Shaping Tomorrow’s Prostate Cancer Therapies
City of Hope, Monty Pal, Tanya Dorff, immunotherapy, prostate cancer, mentor
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Dr. Tanya Dorff, professor in the Department of Medical Oncology & Therapeutics Research and section chief of the Genitourinary Disease Program at City of Hope. Together they dive into Dorff’s pionee…
Nov 25th • 31 mins listen
The Oncology Nursing Podcast
New Guidelines for Managing Immunotherapy-Related Adverse Events
ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educati…
Feb 19th • 13 mins listen
Michael Pietrack
Season 1, Episode 12: The Future of Immuno-Oncology with Mark Frohlich
Michael Pietrack sits down with Mark Frohlich, a Harvard-trained medical Oncologist and CEO of Indapta Therapeutics! He discusses his experience in the Pharmaceutical industry as a pioneer in Immuno-Oncology. He emphasizes the importance of understanding the immune system and the integration of…
May 27th • 19 mins listen
Cancer Buzz Podcast
IO Clinical Trials During COVID-19
On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …
Jun 23rd • 13 mins listen
The Oncology Nursing Podcast
Experiences With CAR T-Cell Therapy
Kathleen Wiley, RN, MSN, AOCNS®, oncology clinical specialist at ONS, sits down with Megan Harvey, MSN, RN, clinical nurse at the Hospital of the University of Pennsylvania, to discuss Harvey's experience with CAR T-cell therapy. Find out more about this immunotherapy treatment in ca…
Oct 24th • 14 mins listen